COONasdaqOphthalmic GoodsFiscal year ends October 31

COOPER COMPANIES, INC.

Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026

$58.16+0.22 (+0.38%)

Close on Oct 19, 2026

Market cap: $11.25B
P/E (TTM): 19.8
Dividend yield: –

COOPER COMPANIES, INC. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-10-31	FY 2024 2024-10-31	FY 2023 2023-10-31	FY 2022 2022-10-31	FY 2021 2021-10-31	FY 2020 2020-10-31	FY 2019 2019-10-31	FY 2018 2018-10-31	FY 2017 2017-10-31	FY 2016 2016-10-31	FY 2015 2015-10-31	FY 2014 2014-10-31	FY 2013 2013-10-31	FY 2012 2012-10-31	FY 2011 2011-10-31	FY 2010 2010-10-31	FY 2009 2009-10-31	FY 2008 2008-10-31
Revenue	4,092	3,895	3,593	3,308	2,923	2,431	2,653	2,533	2,139	1,967	1,797	1,718	1,588	1,445	1,331	1,159	1,080	1,047
Cost of Revenue	1,410	1,300	1,235	1,169	967	896	897	901	773	794	727	626	561	521	526	482	484	437
Gross Profit	2,682	2,596	2,358	2,140	1,956	1,535	1,757	1,632	1,366	1,173	1,070	1,092	1,027	924	805	677	596	610
Research & Development	172	155	137	110	93	93	87	85	69	65	70	66	59	52	44	35	33	35
Selling, General & Admin	1,628	1,534	1,501	1,342	1,211	993	996	973	799	723	713	683	611	565	513	433	392	429
Operating Income	683	706	533	508	506	312	547	403	429	324	237	306	306	283	228	190	150	127
Interest Expense	100	114	105	57	23	37	68	83	33	26	18	7.97	9.17	12	17	37	44	53
Other Non-Operating Income	-16	-9.10	-15	25	8.80	-8.50	-1.30	12	-1.70	-2.30	-3.10	-1.99	1.41	0.23	-0.96	-1.07	7.29	0.03
Merger & Restructuring Charges	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0.42	3.89	1.52
Asset Impairment Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	-7.70	-5.10	-6.10	-31	-42	-9.81	-6.71	-4.27	-12	-7.84	11	-11
Legal Settlements	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	-28	0	0
Pretax Income	567	582	413	475	492	267	477	332	394	296	216	297	312	275	193	124	115	74
Income Tax Expense	192	190	119	90	-2,453	28	11	192	21	21	10	25	15	27	17	12	14	10
Net Income incl. Noncontrolling Interests	–	–	–	–	2,945	238	467	140	373	275	205	272	297	249	175	113	–	–
Minority Interest in Earnings	–	–	–	–	–	–	–	0	0	1.00	1.60	1.97	0.76	0.31	0	0	–	–
Net Income	375	392	294	386	2,945	238	467	140	373	274	204	270	296	248	175	113	101	64
Net Income to Common	–	–	–	386	2,945	238	467	–	–	–	–	–	–	–	–	–	–	–
EPS (Basic)(per share)	1.88	1.97	1.49	1.95	14.95	1.21	2.36	0.71	1.91	1.41	1.05	1.40	1.52	1.30	0.94	0.62	0.56	0.36
EPS (Diluted)(per share)	1.87	1.96	1.48	1.94	14.79	1.20	2.33	0.70	1.88	1.40	1.04	1.38	1.49	1.26	0.91	0.61	0.55	0.36
Shares Outstanding (Basic, Weighted)(shares)	199	199	198	197	197	196	198	196	196	194	194	192	194	192	188	182	181	180
Shares Outstanding (Diluted, Weighted)(shares)	200	200	199	199	199	198	200	199	198	196	197	196	199	197	193	186	182	180
Dividend per Share(per share)	–	–	0.01	0.01	0.0075	0.0075	0.0075	0.0075	0.0075	0.0075	0.0075	0.0075	0.0075	0.0075	–	–	–	–
EBITDA	1,060	1,081	901	854	815	–	828	678	618	522	428	445	431	395	326	284	242	209

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jul 31, 2026

Profitability, TTM

Gross margin: 65.9%
Operating margin: 12.8%
Net margin: 13.5%
Return on equity, FY2025: 4.6%

Financial strength

Current ratio: 1.22
Debt to equity: 0.31
Debt to assets: 20.1%
Cash to current liabilities: 8.3%

Valuation

P/E ratio: 19.8
Price to sales: 2.65
Price to book: 1.35
Dividend yield: –